Your browser doesn't support javascript.
loading
T-Cell Heterogeneity in Baseline Tumor Samples: Implications for Early Clinical Trial Design and Analysis.
Brennan, Laura; Brouwer-Visser, Jurriaan; Nüesch, Eveline; Karpova, Maria; Heller, Astrid; Gaire, Fabien; Schneider, Meike; Gomes, Bruno; Korski, Konstanty.
Afiliación
  • Brennan L; Roche Pharma Research and Early Development, Early Biomarker Development Oncology, Roche Innovation Center New York, Little Falls, NJ, United States.
  • Brouwer-Visser J; Roche Pharma Research and Early Development, Early Biomarker Development Oncology, Roche Innovation Center New York, Little Falls, NJ, United States.
  • Nüesch E; Roche Innovation Center Basel, Roche Pharma and Early Development, Basel, Switzerland.
  • Karpova M; Roche Innovation Center Munich, Roche Pharma and Early Development, Penzberg, Germany.
  • Heller A; Roche Innovation Center Munich, Roche Pharma and Early Development, Penzberg, Germany.
  • Gaire F; Roche Innovation Center Munich, Roche Pharma and Early Development, Penzberg, Germany.
  • Schneider M; Roche Innovation Center Basel, Roche Pharma and Early Development, Basel, Switzerland.
  • Gomes B; Roche Innovation Center Basel, Roche Pharma and Early Development, Basel, Switzerland.
  • Korski K; Roche Innovation Center Munich, Roche Pharma and Early Development, Penzberg, Germany.
Front Immunol ; 13: 760763, 2022.
Article en En | MEDLINE | ID: mdl-35558070

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfocitos Infiltrantes de Tumor / Neoplasias Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfocitos Infiltrantes de Tumor / Neoplasias Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article